Home LiteratureArticle Details
PMID: 41534651 Published · ppublish English

Non-neuronal cell microenvironment control retinal vascular remodeling by CST3 in the oxygen-induced retinopathy in mice.

Experimental eye research ·Vol. 264 ·2026-03-00

Du MY, Qu C, Zhao TJ, Deng YH, Ye L, Tian HP, Li RZ, Li Z, Xu HJ, Li J, Zhou L, Shi Y, Huang LL

Abstract

Retinopathy of prematurity (ROP) remains the leading cause of blindness in premature infants owing to abnormal retinal blood vessels development,but molecular mechanisms are still not fully elucidated. Oxygen-induced retinopathy (OIR) mouse is the extensively used angiogenesis model for the study of ROP pathogenesis. In this study, we investigated five cell types that composed the microenvironment of retinal vessels in OIR mice by single-cell RNA sequencing (scRNA-seq) and revealed a complex and time-dependent regulation of vascular arrest and angiogenesis in the OIR microenvironment. Importantly, we also observe that Müller glia exhibit robust expression of CST3 (cysteine protease inhibitor cystatin C) during the early phase of hypoxic adaptation, leading to capillary morphogenesis in the hyaloid, disrupting physiological vascular patterning and contributing to OIR development. Altogether, our study reveals pivotal roles of the retinal microenvironment in both normal vascularization and ROP progression, suggesting that CST3 is a potential therapeutic target for ROP.

Keywords
Angiogenesis CST3 Oxygen-induced retinopathy Retinal microenvironment Retinopathy of prematurity
Article Info
Journal
Experimental eye research
Abbr.
Exp Eye Res
ISSN
1096-0007
Corresponding email
Published
2026-03-00
Language
English
Country/Region
England
NLM ID
0370707
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]